- Home
- HGV vs PCVX Comparison
HGV vs PCVX Comparison
Compare HGV & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGV
- PCVX
- Stock Information
- Founded
- HGV 1992
- PCVX 2013
- Country
- HGV United States
- PCVX United States
- Employees
- HGV N/A
- PCVX N/A
- Industry
- HGV Hotels/Resorts
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- HGV Consumer Discretionary
- PCVX Health Care
- Exchange
- HGV Nasdaq
- PCVX Nasdaq
- Market Cap
- HGV 3.7B
- PCVX 6.0B
- IPO Year
- HGV N/A
- PCVX 2020
- Fundamental
- Price
- HGV $39.50
- PCVX $49.03
- Analyst Decision
- HGV Buy
- PCVX Strong Buy
- Analyst Count
- HGV 7
- PCVX 7
- Target Price
- HGV $50.86
- PCVX $101.67
- AVG Volume (30 Days)
- HGV 1.0M
- PCVX 1.3M
- Earning Date
- HGV 10-30-2025
- PCVX 11-04-2025
- Dividend Yield
- HGV N/A
- PCVX N/A
- EPS Growth
- HGV N/A
- PCVX N/A
- EPS
- HGV 0.56
- PCVX N/A
- Revenue
- HGV $4,470,000,000.00
- PCVX N/A
- Revenue This Year
- HGV $15.92
- PCVX N/A
- Revenue Next Year
- HGV $8.17
- PCVX N/A
- P/E Ratio
- HGV $71.13
- PCVX N/A
- Revenue Growth
- HGV 5.47
- PCVX N/A
- 52 Week Low
- HGV $30.59
- PCVX $27.66
- 52 Week High
- HGV $52.08
- PCVX $98.17
- Technical
- Relative Strength Index (RSI)
- HGV 38.58
- PCVX 69.14
- Support Level
- HGV $39.08
- PCVX $40.14
- Resistance Level
- HGV $41.02
- PCVX $45.90
- Average True Range (ATR)
- HGV 1.38
- PCVX 2.30
- MACD
- HGV -0.24
- PCVX 0.26
- Stochastic Oscillator
- HGV 15.23
- PCVX 91.15
About HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts, timeshare plans, and ancillary reservation services, under the Hilton Grand Vacations brand. The company operates business in the following two segments: (i) Real estate sales and financing and (ii) Resort operations and club management. The majority of the company's revenue is earned through the Real estate sales and financing segment, which generates revenue from VOI sales, and Financing.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.